Befejeződött1. fázis
A study investigating the safety, tolerability, pharmacokinetics (absorption, distribution, metabolism and elimination) and effect of single and multiple doses of MTX46943, a new compound that may potentially be used in the treatment of Alzheimer’s disease and other neurological disorders
Key facts
- Where
- Groningen, HollandiaSee the site
- Phase
- 1. fázis
Where in Hollandia
- Pharmaceutical Research Associates Group B.V.Groningen, HollandiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Muna Therapeutics ApS
- Trial code
- EU 2025-522368-34-00
- Record updated
- 2026. február 26.